|
MLL4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.86937999999692E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.443000E-04 |
| Normal-vs-Stage2 |
3.190500E-04 |
| Normal-vs-Stage3 |
1.65889999999003E-05 |
| Normal-vs-Stage4 |
2.481500E-03 |
| Stage1-vs-Stage2 |
3.621200E-01 |
| Stage1-vs-Stage3 |
1.676770E-01 |
| Stage1-vs-Stage4 |
9.474000E-01 |
| Stage2-vs-Stage3 |
9.219600E-01 |
| Stage2-vs-Stage4 |
4.718800E-01 |
| Stage3-vs-Stage4 |
3.496600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.189010E-04 |
| Normal-vs-AfricanAmerican |
4.726400E-02 |
| Normal-vs-Asian |
2.503600E-02 |
| Caucasian-vs-AfricanAmerican |
5.256400E-01 |
| Caucasian-vs-Asian |
2.840800E-01 |
| AfricanAmerican-vs-Asian |
8.680800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.360600E-04 |
| Normal-vs-Female |
1.52132999999832E-05 |
| Male-vs-Female |
3.865400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.561700E-04 |
| Normal-vs-Age(41-60Yrs) |
8.49179999999894E-05 |
| Normal-vs-Age(61-80Yrs) |
2.27599999998995E-05 |
| Normal-vs-Age(81-100Yrs) |
2.347600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.441200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.753210E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.375400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.338600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.686600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.263400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.047650E-04 |
| Classical-VS-Follicular |
2.304400E-03 |
| Classical-VS-Other |
4.001800E-01 |
| Classical-VS-Normal |
1.183420E-03 |
| Tall-VS-Follicular |
5.196000E-01 |
| Tall-VS-Other |
3.800200E-01 |
| Tall-VS-Normal |
2.21179999981835E-07 |
| Follicular-VS-Other |
7.448200E-01 |
| Follicular-VS-Normal |
1.73338999999162E-05 |
| Other-VS-Normal |
5.896300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.27059999999835E-05 |
| Normal-vs-N1 |
6.863700E-03 |
| N0-vs-N1 |
4.124200E-01 |
|
|
